MedPath
TGA Approval

FASENRA benralizumab 30 mg in 1 mL solution for injection prefilled syringe (285718)

285718

FASENRA benralizumab 30 mg in 1 mL solution for injection prefilled syringe

AstraZeneca Pty Ltd

April 3, 2018

Medicine

Medicine

Active

Registered

Product Information

Product Information

https://medical-cdn.nocode.com/drug_tga/1bbed5eacc90d80da154b15032d5c1e3.pdf

Active Ingredients

benralizumab

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

FASENRA benralizumab 30 mg in 1 mL solution for injection prefilled syringe (285718) - TGA 批准文号 | MedPath